US regulators approve 2nd gene therapy for blood cancer – ABC News
Forbes |
US regulators approve 2nd gene therapy for blood cancer
ABC News On Wednesday, Oct. 18, 2017, the Food and Drug Administration approved sales of the therapy Yescarta, developed by Kite Pharma. It is the second gene therapy for U.S. patients _ the first one for adults _ a custom-made, one-time treatment for certain … FDA Approves Another Amazing And Costly Cancer-Killing Gene Therapy US FDA approves Gilead cancer gene therapy; price set at $373000 FDA approves first gene therapy for adults with blood cancer |
